Nevirapine Patent Expiration
Nevirapine is Used for managing HIV-1 infection through once-daily administration. It was first introduced by Boehringer Ingelheim Pharmaceuticals Inc
Nevirapine Patents
Given below is the list of patents protecting Nevirapine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Viramune Xr | US8460704 | Extended release formulation of nevirapine | Mar 12, 2029 | Boehringer Ingelheim |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Nevirapine's patents.
Latest Legal Activities on Nevirapine's Patents
Given below is the list recent legal activities going on the following patents of Nevirapine.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 21 Sep, 2020 | US8460704 |
| Post Issue Communication - Certificate of Correction | 05 Feb, 2015 | US8460704 |
| Email Notification Critical
| 13 Sep, 2014 | US8460704 |
| Mail-Record a Petition Decision of Granted for Patent Term Adjustment after Allowance | 10 Sep, 2014 | US8460704 |
| Record a Petition Decision of Granted for Patent Term Adjustment after Allowance | 09 Sep, 2014 | US8460704 |
| Adjustment of PTA Calculation by PTO | 05 Sep, 2014 | US8460704 |
| Petition Entered | 14 Jun, 2013 | US8460704 |
| Recordation of Patent Grant Mailed Critical
| 11 Jun, 2013 | US8460704 |
| Patent Issue Date Used in PTA Calculation Critical
| 11 Jun, 2013 | US8460704 |
| Email Notification Critical
| 23 May, 2013 | US8460704 |
Nevirapine's Family Patents
